News
AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...
AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
AstraZeneca’s chief executive has said the drugmaker is a “very American company” amid growing speculation it will shift its ...
AstraZeneca adjusts its U.S. strategy by proposing drug price cuts and expanding local production in response to pressure ...
AstraZeneca (NASDAQ:AZN) has announced an interim dividend of $1.03/share. The record date for the first interim dividend for 2025, payable on September 8, 2024, will be August ...
Jefferies analysts note that FX was a significant headwind and it wasn’t quite clear the extent to which that had been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback